Covered recipient · General Payments record
TRACY LARGADO INGRAM
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2023–2024
$591.94
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $342.60 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $118.85 | 6 |
| Alkermes, Inc. | $75.49 | 4 |
| Neurocrine BioSciences, Inc. | $68.45 | 3 |
| Lundbeck LLC | $49.81 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.85 | 1 |
| Teva Pharmaceuticals USA, Inc. | $13.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.20 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107383152 | CMS |
| ABBVIE INC. | $18.69 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107383154 | CMS |
| ABBVIE INC. | $26.55 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107383156 | CMS |
| ABBVIE INC. | $20.92 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107383158 | CMS |
| ABBVIE INC. | $13.74 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107383160 | CMS |
| ABBVIE INC. | $13.75 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107383162 | CMS |
| Alkermes, Inc. | $14.94 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120521381 | CMS |
| Alkermes, Inc. | $21.62 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120521383 | CMS |
| Alkermes, Inc. | $16.38 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120521385 | CMS |
| Alkermes, Inc. | $22.55 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120521387 | CMS |
| Lundbeck LLC | $32.97 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146039022 | CMS |
| Lundbeck LLC | $16.84 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146039024 | CMS |
| Neurocrine Biosciences, Inc. | $27.20 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150947241 | CMS |
| Neurocrine Biosciences, Inc. | $26.79 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150948511 | CMS |
| Neurocrine Biosciences, Inc. | $14.46 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151006065 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.85 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137767691 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.15 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151751740 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.